David D. Waters

6.6k total citations · 1 hit paper
37 papers, 4.8k citations indexed

About

David D. Waters is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, David D. Waters has authored 37 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Surgery, 15 papers in Cardiology and Cardiovascular Medicine and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in David D. Waters's work include Lipoproteins and Cardiovascular Health (24 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). David D. Waters is often cited by papers focused on Lipoproteins and Cardiovascular Health (24 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Health Systems, Economic Evaluations, Quality of Life (11 papers). David D. Waters collaborates with scholars based in United States, Netherlands and Australia. David D. Waters's co-authors include John J.P. Kastelein, Philip J. Barter, Nanette K. Wenger, John C. LaRosa, Scott M. Grundy, James Shepherd, Jean‐Charles Fruchart, Antonio M. Gotto, Charles L. Shear and Heiner Greten and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

David D. Waters

36 papers receiving 4.6k citations

Hit Papers

Intensive Lipid Lowering with Atorvastatin in Patients wi... 2005 2026 2012 2019 2005 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease
    2005 2.5k citations John C. LaRosa, Scott M. Grundy et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David D. Waters United States 22 3.5k 1.7k 1.4k 1.1k 662 37 4.8k
Andrew M. Tershakovec United States 24 3.6k 1.0× 1.5k 0.9× 1.3k 0.9× 1.3k 1.2× 691 1.0× 55 5.1k
Gabriele Riccardi Italy 14 3.0k 0.9× 1.6k 0.9× 1.5k 1.1× 972 0.9× 583 0.9× 20 4.5k
S. Féasson France 4 3.7k 1.1× 1.5k 0.9× 1.6k 1.2× 1.2k 1.1× 631 1.0× 6 5.4k
David A. DeMicco United States 33 2.6k 0.8× 1.8k 1.1× 1.5k 1.1× 600 0.6× 534 0.8× 69 4.5k
C Pollicino Australia 6 3.5k 1.0× 1.6k 1.0× 1.3k 1.0× 1.3k 1.2× 852 1.3× 9 5.1k
T. Sourjina Australia 8 3.6k 1.0× 1.6k 0.9× 1.3k 1.0× 1.3k 1.2× 929 1.4× 9 5.3k
Polly A. Beere United States 12 4.0k 1.2× 2.2k 1.3× 1.9k 1.3× 1.3k 1.2× 917 1.4× 18 5.9k
Evan A. Stein United States 27 2.6k 0.8× 1.7k 1.0× 818 0.6× 690 0.6× 616 0.9× 59 4.7k
Heiner Greten Germany 33 3.2k 0.9× 1.7k 1.0× 1.2k 0.9× 875 0.8× 696 1.1× 78 5.3k
Christopher Isles United Kingdom 10 4.9k 1.4× 2.3k 1.3× 1.8k 1.3× 1.6k 1.5× 951 1.4× 19 7.1k

Countries citing papers authored by David D. Waters

Since Specialization
Citations

This map shows the geographic impact of David D. Waters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David D. Waters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David D. Waters more than expected).

Fields of papers citing papers by David D. Waters

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David D. Waters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David D. Waters. The network helps show where David D. Waters may publish in the future.

Co-authorship network of co-authors of David D. Waters

This figure shows the co-authorship network connecting the top 25 collaborators of David D. Waters. A scholar is included among the top collaborators of David D. Waters based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David D. Waters. David D. Waters is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arsenault, Benoît J., Francine Petrides, Fatiha Tabet, et al.. (2017). Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk. Journal of clinical lipidology. 12(1). 130–136. 46 indexed citations
2.
Waters, David D.. (2015). LDL-cholesterol lowering and renal outcomes. Current Opinion in Lipidology. 26(3). 195–199. 11 indexed citations
3.
Hsue, Priscilla Y., Vera Bittner, John Betteridge, et al.. (2014). Impact of Female Sex on Lipid Lowering, Clinical Outcomes, and Adverse Effects in Atorvastatin Trials. The American Journal of Cardiology. 115(4). 447–453. 41 indexed citations
4.
Waters, David D., Jennifer E. Ho, S. Matthijs Boekholdt, et al.. (2012). Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy. Journal of the American College of Cardiology. 61(2). 148–152. 133 indexed citations
5.
Waters, David D., Jennifer E. Ho, David A. DeMicco, et al.. (2011). Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin. Journal of the American College of Cardiology. 57(14). 1535–1545. 246 indexed citations
6.
Bittner, Vera, Nanette K. Wenger, David D. Waters, et al.. (2010). VITAMIN D LEVELS DO NOT PREDICT CARDIOVASCULAR EVENTS IN STATIN-TREATED PATIENTS WITH STABLE CORONARY DISEASE. Journal of the American College of Cardiology. 55(10). A167.E1570–A167.E1570. 4 indexed citations
7.
Waters, David D.. (2009). What do the statin trials tell us?. Clinical Cardiology. 24(S3). 3–7. 4 indexed citations
8.
9.
Jones, Roy, Miia Kivipelto, Howard Feldman, et al.. (2008). The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Design and baseline characteristics. Alzheimer s & Dementia. 4(2). 145–153. 53 indexed citations
10.
LaRosa, John C., Scott M. Grundy, David D. Waters, et al.. (2005). Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary Disease. New England Journal of Medicine. 352(14). 1425–1435. 2485 indexed citations breakdown →
11.
Dornelas, Ellen A., et al.. (2000). A Randomized Controlled Trial of Smoking Cessation Counseling after Myocardial Infarction. Preventive Medicine. 30(4). 261–268. 144 indexed citations
12.
Waters, David D., et al.. (1998). Does the type of vasodilator stress influence defect extent with Tc-99m tetrofosmin SPECT imaging?. Journal of the American College of Cardiology. 31. 301–301. 1 indexed citations
13.
Giri, Satyendra, Paul D. Thompson, John H. Contois, et al.. (1998). Oral estrogen improves serum lipids, homocysteine and fibrinolysis in elderly men. Atherosclerosis. 137(2). 359–366. 81 indexed citations
14.
15.
Azar, Rabih R., Raymond G. McKay, Francis J. Kiernan, et al.. (1997). Coronary Angioplasty Induces a Systemic Inflammatory Response. The American Journal of Cardiology. 80(11). 1476–1478. 73 indexed citations
16.
Mitchel, Joseph F., Raymond G. McKay, Michael Azrin, et al.. (1997). Effect of low grade radiofrequency heating on arterial vasospasm in the porcine model. Catheterization and Cardiovascular Diagnosis. 42(3). 348–355. 4 indexed citations
17.
Fram, Daniel B., Thomas Aretz, Michael Azrin, et al.. (1994). Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. Journal of the American College of Cardiology. 23(7). 1570–1577. 49 indexed citations
18.
Küpper, W., Christian W. Hamm, W. Bleifeld, et al.. (1994). Efficacy of high dose intravenous heparin for treatment of left ventricular thrombi with high embolic risk. Journal of the American College of Cardiology. 24(5). 1305–1309. 47 indexed citations
19.
Fram, Daniel B., Thomas Aretz, Joseph F. Mitchel, et al.. (1993). In vivo radiofrequency thermal balloon angioplasty of porcine coronary arteries: Histologic effects and safety. American Heart Journal. 126(4). 969–978. 15 indexed citations
20.
Waters, David D. & Pierre Théroux. (1987). Whither the coronary care unit?. PubMed. 136(1). 17–9. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew M. Tershakovec Breakdown of academic impact, for papers by Gabriele Riccardi Breakdown of academic impact, for papers by S. Féasson Breakdown of academic impact, for papers by David A. DeMicco Breakdown of academic impact, for papers by C Pollicino Breakdown of academic impact, for papers by T. Sourjina Breakdown of academic impact, for papers by Polly A. Beere Breakdown of academic impact, for papers by Evan A. Stein Breakdown of academic impact, for papers by Heiner Greten Breakdown of academic impact, for papers by Christopher Isles
Rankless by CCL
2026